Consumers Pulling A Fast One In Cymbalta Case, Eli Lilly Says

Law360, New York (October 14, 2015, 8:11 PM EDT) -- Eli Lilly & Co. told a California federal judge Wednesday that three consumers accusing the company of concealing the withdrawal risks of its antidepressant Cymbalta are trying to drop their claims in a transparent bid for a second chance to appeal orders denying their motions for class certification.

Eli Lilly has come out on top in the first three Cymbalta personal injury suits to go to trial. (Credit: AP) Melissa Strafford, Carol Jacquez and David Matthews Jr. have moved to dismiss their claims with prejudice, and the pharmaceutical company said their motion amounts to a second interlocutory appeal to the Ninth...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!